Skip to main content

Advertisement

Log in

Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case–control studies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Interferon gamma (IFN-γ) plays a pivotal role in antiproliferative, antitumor and antiviral activities. The +874 polymorphism in IFN gene region reportedly affects cancer risk. However, pertinent studies offer conflicting results. To derive a more precise estimation, we performed a meta-analysis based on 1,929 cases and 2,830 controls from 17 published case–control studies, assessing the strength of the association using odds ratios with 95% confidence intervals. Our meta-analysis showed the evidence that IFN-γ +874 T/A was not associated with increased cancer risk in ethnicity and source of controls. However, stratified analysis by cancer type indicated a significantly increased risk of cervical cancer (AT vs. TT: OR = 1.10, 95% CI = 1.02–1.19, P = 0.961 for heterogeneity). Further prospective researches with a larger single study are required to evaluate any association with other types of cancer or in other populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Song SH, Lee JK, Lee NW, Saw HS, Kang JS, Lee KW (2008) Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol 108:543–548

    Article  PubMed  CAS  Google Scholar 

  2. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264

    Article  PubMed  CAS  Google Scholar 

  3. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto YXY (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1. Science 272:719–722

    Article  PubMed  CAS  Google Scholar 

  4. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE Jr (1996) Transcriptionally active Stat1 is required for the anti-proliferative effects of both interferon-α and interferon-γ. Proc Natl Acad Sci USA 93:7673–7678

    Article  PubMed  CAS  Google Scholar 

  5. Mandal M, Bandyopadhyay D, Goepfert TM, Kumar R (1998) Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene 16:217–225

    Article  PubMed  CAS  Google Scholar 

  6. Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC (1998) Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1α for inhibition by interferon-γ. Cancer Res 58:840–847

    PubMed  CAS  Google Scholar 

  7. Chen B, He L, Savell VH, Jenkins JJ, Parham DM (2000) Inhibition of the interferon-γ/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res 60:3290–3298

    PubMed  CAS  Google Scholar 

  8. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364

    Article  PubMed  CAS  Google Scholar 

  9. Folkman J (1999) Angiogenic zip code. Nat Biotechnol 17:749

    Article  PubMed  CAS  Google Scholar 

  10. Calvo J, Martínez N, Etxagibel A, Calleja S, Sáez-torres C, Sedeño M, Julià R, Muncunill J, Matamoros N, Gayà A (2002) Allelic frequencies of polymorphic variants of cytokine genes (IL1A, IL1B, IL1RN, IL6, IL10, IL12p40, and IFNG) in a Spanish population. Inmunologia 21(2):76–86

    Google Scholar 

  11. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchison IV (1999) In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 26:1–3

    Article  PubMed  CAS  Google Scholar 

  12. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 61:863–866

    Article  PubMed  CAS  Google Scholar 

  13. Matos GI, Covas Cde J, Bittar Rde C, Gomes-Silva A, Marques F, Maniero VC, Amato VS, Oliveira-Neto MP, Mattos Mda S, Pirmez C, Sampaio EP, Moraes MO, Da-Cruz AM (2007) IFNγ +874 T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production. BMC Infect Dis 7:33

    Article  PubMed  Google Scholar 

  14. Horvath CM (2004) The Jak-STAT pathway stimulated by interferon gamma. Sci STKE 260:tr8

    Article  Google Scholar 

  15. Gough DJ, Levy DE, Johnstone RW, Clarke CJ (2008) IFN gamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev 19:383–394

    Article  PubMed  CAS  Google Scholar 

  16. Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, Pirulli D, Floege J, Mertens PR, Zerres K, Alexopoulos E, Kirmizis D, Zelante L, Bisceglia L (2006) Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet 14:488–496

    Article  PubMed  CAS  Google Scholar 

  17. Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Raimondi C, Accardo A, Verna R, Candore G, Caruso C, Lio D, Palmeri S (2006) Cytokine gene polymorphisms and breast cancer susceptibility. Ann NY Acad Sci 1089:104–109

    Article  PubMed  CAS  Google Scholar 

  18. Kamali-Sarvestani E, Merat A, Talei AR (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223:113–119

    Article  PubMed  CAS  Google Scholar 

  19. Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, Manavoglu O (2007) Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J 28:1728–1733

    PubMed  Google Scholar 

  20. Gangwar R, Pandey S, Mittal RD (2009) Association of interferon-gamma +874 A polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG 116:1671–1677

    Article  PubMed  CAS  Google Scholar 

  21. Kordi Tamandani MK, Sobti RC, Shekari M, Mukesh M, Suri V (2008) Expression and polymorphism of IFN-gamma gene in patients with cervical cancer. Exp Oncol 30:224–229

    PubMed  CAS  Google Scholar 

  22. Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL (2003) Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog 2:3

    Article  PubMed  Google Scholar 

  23. Nikolova PN, Pawelec GP, Mihailova SM (2007) Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother 56:371–379

    Article  PubMed  CAS  Google Scholar 

  24. Howell WM, Turner SJ, Theaker JM, Bateman AC (2003) Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30:409–414

    Article  PubMed  CAS  Google Scholar 

  25. Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L (2008) Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35:197–205

    Article  PubMed  CAS  Google Scholar 

  26. Colakogullari M, Ulukaya E, Yilmaztepe Oral A, Aymak F, Basturk B, Ursavas A, Oral HB (2008) The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26:283–290

    Article  PubMed  CAS  Google Scholar 

  27. Nearman ZP, Wlodarski M, Jankowska AM, Howe E, Narvaez Y, Ball E, Maciejewski JP (2007) Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol 136:237–248

    Article  PubMed  CAS  Google Scholar 

  28. Baştürk B, Yavaşçaoğlu I, Vuruşkan H, Göral G, Oktay B, Oral HB (2005) Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 30:41–45

    Article  PubMed  Google Scholar 

  29. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K (2005) Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 42:505–510

    Article  PubMed  CAS  Google Scholar 

  30. Ahirwar DK, Agrahari A, Mandhani A, Mittal RD (2009) Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers 14:213–218

    Article  PubMed  CAS  Google Scholar 

  31. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ (2007) Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 42:628–632

    Article  PubMed  CAS  Google Scholar 

  32. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E (2009) Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma 56:56–62

    Article  PubMed  CAS  Google Scholar 

  33. Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  Google Scholar 

  34. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  35. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629–634

    PubMed  CAS  Google Scholar 

  36. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-c an overview of signals mechanisms and functions. J Leukoc Biol 75:163–189

    Article  PubMed  CAS  Google Scholar 

  37. Tartour E, Gey A, Sastre-Garau X, Lombard Surin I, Mosseri V, Fridman WH (1998) Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 90:287–294

    Article  PubMed  CAS  Google Scholar 

  38. Gey A, Kumari P, Sambandam A, Lecuru F, Cassard L, Badoual C, Fridman C, Nagarajan B, Fridman WH, Tartour E (2003) Identification and characterization of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFN gamma) and Type 2 (IL-4) cytokine mRNA expression. Eur J Cancer 39:595–603

    Article  PubMed  CAS  Google Scholar 

  39. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL (2005) Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 6:358–363

    Article  PubMed  CAS  Google Scholar 

  40. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  41. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR (2000) Repair of tobacco carcinogen induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92:1764–1772

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ning-Han Feng or Yong Yao.

Additional information

Yuan-Yuan Mi, Qian-Qian Yu and Bin Xu have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mi, YY., Yu, QQ., Xu, B. et al. Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case–control studies. Mol Biol Rep 38, 4461–4467 (2011). https://doi.org/10.1007/s11033-010-0575-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0575-3

Keywords

Navigation